MAPS

WIPO WIPO 2021

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke MAPS wurde als Wortmarke am 25.05.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 09. März 2023

Markenform Wortmarke
Aktenzeichen 1630106
Länder Kanada
Basismarke US Nr. , 09. August 2024
Anmeldedatum 25. Mai 2021
Ablaufdatum 25. Mai 2031

Markeninhaber

3141 Stevens Creek Blvd., #40563
San Jose CA 95117
US

Markenvertreter

774 Mays Blvd, No 10-405 Incline Village NV 89451 US

Waren und Dienstleistungen

16 Printed publications, namely, brochures, booklets, and teaching materials in the field of psychedelic research, psychotherapeutic treatments and therapies, mdma therapies, medical marijuana, lsd-assisted psychotherapy, ibogaine-assisted treatment, ayahuasca-assisted therapy, mental health care and mental well-being, psychedelic substances and science
35 Database management; online retail and pop-up retail stores featuring manuals and guides in the field of science, video recordings, jewelry, clothing, art, books, guides, water bottles, computer accessories and artifacts; providing independent review of clinical trials for business purposes; promoting the interests of ptsd patients and their families by means of public advocacy (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); promoting public awareness of psychedelic research, psychotherapeutic treatments and therapies, mdma therapies, medical marijuana, lsd-assisted psychotherapy, ibogaine-assisted treatment, ayahuasca-assisted therapy, mental health care and mental well-being by means of public advocacy (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations)
36 Accepting and administering monetary charitable contributions; accepting and administering monetary charitable contributions to fund medical research; charitable fundraising
41 Educational services, namely, providing trainings on psychedelic research, psychotherapeutic treatments and therapies, mdma therapies, medical marijuana, lsd-assisted psychotherapy, ibogaine-assisted treatment, ayahuasca-assisted therapy, mental health care and mental well-being and distributing printed educational materials in connection therewith; educational services, namely, providing trainings on mental health care and mental well-being and distributing printed educational materials in connection therewith; educational services, namely, conducting workshops, seminars, trainings and conferences in the fields of mental health and wellness, mental wellbeing, mind-altering substances and science and distributing printed educational materials in connection therewith; on-line electronic newsletters delivered by e-mail in the fields of psychedelic research, psychotherapeutic treatments and therapies, mdma therapies, medical marijuana, lsd-assisted psychotherapy, ibogaine-assisted treatment, ayahuasca-assisted therapy, mental health care and mental well-being, mind-altering substances and science (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); on-line library services, namely, providing electronic library services which feature newspapers, research articles, magazines, photographs and pictures via an on-line computer network; online non-downloadable periodicals in the nature of bulletins and newsletters in the fields of psychedelic research, psychotherapeutic treatments and therapies, mdma therapies, medical marijuana, lsd-assisted psychotherapy, ibogaine-assisted treatment, ayahuasca-assisted therapy, mental health care and mental well-being, mind-altering substances and science and psychedelic harm reduction (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); entertainment services, namely, providing podcasts in the field of psychedelic research, psychotherapeutic treatments and therapies, mdma therapies, medical marijuana, lsd-assisted psychotherapy, ibogaine-assisted treatment, ayahuasca-assisted therapy, mental health care and mental well-being, mind-altering substances and science and psychedelic harm reduction (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); education services, namely, providing non-downloadable webinars in the field of psychedelic research, psychotherapeutic treatments and therapies, mdma therapies, medical marijuana, lsd-assisted psychotherapy, ibogaine-assisted treatment, ayahuasca-assisted therapy, mental health care and mental well-being, mind-altering substances and science and psychedelic harm reduction; public educational events, namely, providing conferences and seminars, public education classes, and trainings and book signing events for entertainment purposes, all in the field of psychedelic research, psychotherapeutic treatments and therapies, mdma therapies, medical marijuana, lsd-assisted psychotherapy, ibogaine-assisted treatment, ayahuasca-assisted therapy, mental health care and mental well-being, mind-altering substances and science and psychedelic harm reduction; none of the foregoing involving possession, distribution or dispensing of controlled substances
44 Providing an online computer database featuring information about mental health professionals and mental health care facilities (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); providing an on-line computer database featuring information, articles and links in the field of psychotherapeutic treatments, mdma- and other psychedelic-assisted therapies, treatment of diseases and disorders of the central nervous system and mental health disorders (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations)
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
07. März 2023 2023/10 Gaz CA Ablehnung
25. Mai 2021 2021/46 Gaz US Eintragung

ID: 141630106